Overview
Hypophosphatemic rickets is a group of rare genetic disorders characterized by renal phosphate wasting, leading to chronically low levels of phosphate in the blood (hypophosphatemia) and defective mineralization of bones and teeth. The most common form is X-linked hypophosphatemic rickets (XLH), caused by mutations in the PHEX gene, but autosomal dominant and autosomal recessive forms also exist (caused by mutations in FGF23, DMP1, ENPP1, CLCN5, and other genes). The condition is also known as vitamin D-resistant rickets because it does not respond to standard vitamin D supplementation. The disease primarily affects the skeletal system, leading to bowing of the legs, short stature, bone pain, and fractures. In children, the hallmark features include progressive leg bowing (genu varum or genu valgum), widening of the wrists and knees, delayed walking, waddling gait, and impaired growth. Dental manifestations are common and include spontaneous dental abscesses, enamel defects, and enlarged pulp chambers. Adults may experience osteomalacia, enthesopathies (calcification of tendons and ligaments), joint stiffness, pseudofractures, hearing loss, and chronic musculoskeletal pain. The kidneys are functionally involved as the primary site of phosphate loss, though kidney function is otherwise typically preserved. Traditional treatment has consisted of oral phosphate supplementation combined with active vitamin D analogs (calcitriol or alfacalcidol) to improve phosphate balance and promote bone mineralization. However, this regimen requires careful monitoring due to risks of nephrocalcinosis and secondary hyperparathyroidism. A major therapeutic advance came with the approval of burosumab (Crysvita), a monoclonal antibody targeting FGF23, which has been shown to significantly improve phosphate levels, rickets severity, growth, and pain in both children and adults with XLH. Orthopedic surgery may be needed for severe skeletal deformities that persist despite medical treatment.
Variable
Can be inherited in different ways depending on the underlying gene
Childhood
Begins in childhood, roughly ages 1 to 12
Treatments
No FDA-approved treatments are currently listed for Hypophosphatemic rickets.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Hypophosphatemic rickets at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Hypophosphatemic rickets.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Hypophosphatemic rickets.
Community
No community posts yet. Be the first to share your experience with Hypophosphatemic rickets.
Start the conversation →Latest news about Hypophosphatemic rickets
No recent news articles for Hypophosphatemic rickets.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Hypophosphatemic rickets
What is Hypophosphatemic rickets?
Hypophosphatemic rickets is a group of rare genetic disorders characterized by renal phosphate wasting, leading to chronically low levels of phosphate in the blood (hypophosphatemia) and defective mineralization of bones and teeth. The most common form is X-linked hypophosphatemic rickets (XLH), caused by mutations in the PHEX gene, but autosomal dominant and autosomal recessive forms also exist (caused by mutations in FGF23, DMP1, ENPP1, CLCN5, and other genes). The condition is also known as vitamin D-resistant rickets because it does not respond to standard vitamin D supplementation. The d
At what age does Hypophosphatemic rickets typically begin?
Typical onset of Hypophosphatemic rickets is childhood. Age of onset can vary across affected individuals.